دورية أكاديمية
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
| العنوان: | First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study |
|---|---|
| المؤلفون: | D’Angelo, S.P., Lebbé, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J.-J., Prinzi, N., Hanna, G.J., Hassel, J.C., Kiecker, F., von Heydebreck, A., Güzel, G., Nghiem, P. |
| المصدر: | In ESMO Open May 2024 9(5) |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 20597029 |
|---|---|
| DOI: | 10.1016/j.esmoop.2024.103461 |